ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 157 filers reported holding ANIKA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,777,000 | +23.7% | 77,137 | +20.9% | 0.00% | 0.0% |
Q3 2016 | $3,053,000 | -11.0% | 63,801 | -0.2% | 0.00% | 0.0% |
Q2 2016 | $3,429,000 | +27.1% | 63,907 | +5.9% | 0.00% | 0.0% |
Q1 2016 | $2,698,000 | +19.1% | 60,339 | +1.6% | 0.00% | +33.3% |
Q4 2015 | $2,266,000 | +20.6% | 59,388 | +0.6% | 0.00% | 0.0% |
Q3 2015 | $1,879,000 | -4.5% | 59,036 | -0.9% | 0.00% | +50.0% |
Q2 2015 | $1,968,000 | -5.5% | 59,590 | +17.8% | 0.00% | -33.3% |
Q1 2015 | $2,083,000 | +2.5% | 50,596 | +1.5% | 0.00% | 0.0% |
Q4 2014 | $2,032,000 | +10.6% | 49,869 | -0.5% | 0.00% | 0.0% |
Q3 2014 | $1,838,000 | -17.7% | 50,135 | +4.0% | 0.00% | 0.0% |
Q2 2014 | $2,232,000 | +27.3% | 48,186 | +13.0% | 0.00% | 0.0% |
Q1 2014 | $1,753,000 | +8.3% | 42,647 | +0.6% | 0.00% | +50.0% |
Q4 2013 | $1,618,000 | +82.8% | 42,410 | +14.4% | 0.00% | +100.0% |
Q3 2013 | $885,000 | +44.1% | 37,056 | +2.6% | 0.00% | 0.0% |
Q2 2013 | $614,000 | – | 36,126 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,375 | $1,225,000 | 2.02% |
CAPITAL MANAGEMENT CORP /VA | 92,905 | $2,686,000 | 0.98% |
Avidity Partners Management LP | 168,000 | $4,857,000 | 0.67% |
DIKER MANAGEMENT LLC | 21,935 | $634,000 | 0.27% |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,327,397 | $38,375,000 | 0.22% |
Intercontinental Wealth Advisors, LLC | 12,468 | $360,000 | 0.19% |
Boston Trust Walden Corp | 326,319 | $9,434,000 | 0.15% |
Matarin Capital Management, LLC | 32,599 | $942,000 | 0.15% |
Cove Street Capital, LLC | 20,000 | $578,000 | 0.12% |
OAKTOP CAPITAL MANAGEMENT II, L.P. | 12,500 | $361,000 | 0.11% |